Swiss National Bank Royalty Pharma PLC Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Royalty Pharma PLC stock. As of the latest transaction made, Swiss National Bank holds 1,140,600 shares of RPRX stock, worth $29.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,140,600

Previous 1,123,600 1.51%

Holding current value

$29.2 Million

Previous $29.6 Million 8.9%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$25.63 - $29.27 $435,710 - $497,590	17,000 Added 1.51%	1,140,600 $32.3 Million
Q2 2024 Aug 08, 2024	SELL	$26.26 - $29.9 $351,884 - $400,660	-13,400 Reduced 1.18%	1,123,600 $29.6 Million
Q1 2024 May 07, 2024	SELL	$27.46 - $31.33 $1.54 Million - $1.76 Million	-56,200 Reduced 4.71%	1,137,000 $34.5 Million
Q4 2023 Feb 06, 2024	SELL	$26.21 - $29.22 $846,583 - $943,806	-32,300 Reduced 2.64%	1,193,200 $33.5 Million
Q3 2023 Nov 08, 2023	SELL	$26.26 - $31.38 $3.54 Million - $4.23 Million	-134,800 Reduced 9.91%	1,225,500 $33.3 Million
Q2 2023 Aug 09, 2023	SELL	$29.6 - $36.56 $1.19 Million - $1.47 Million	-40,100 Reduced 2.86%	1,360,300 $41.8 Million
Q1 2023 May 10, 2023	SELL	$32.77 - $39.4 $684,893 - $823,460	-20,900 Reduced 1.47%	1,400,400 $50.5 Million
Q4 2022 Feb 08, 2023	SELL	$39.17 - $44.04 $3.44 Million - $3.87 Million	-87,910 Reduced 5.82%	1,421,300 $56.2 Million
Q3 2022 Nov 09, 2022	BUY	$39.88 - $44.65 $267,196 - $299,155	6,700 Added 0.45%	1,509,210 $60.6 Million
Q2 2022 Aug 09, 2022	BUY	$37.53 - $44.22 $532,926 - $627,924	14,200 Added 0.95%	1,502,510 $63.2 Million
Q1 2022 May 09, 2022	BUY	$37.46 - $42.44 $7.11 Million - $8.06 Million	189,800 Added 14.62%	1,488,310 $58 Million
Q4 2021 Feb 08, 2022	BUY	$35.17 - $42.48 $21.1 Million - $25.5 Million	599,500 Added 85.76%	1,298,510 $51.7 Million
Q3 2021 Nov 08, 2021	SELL	$36.14 - $42.24 $560,170 - $654,720	-15,500 Reduced 2.17%	699,010 $25.3 Million
Q2 2021 Aug 06, 2021	BUY	$39.85 - $46.63 $1.71 Million - $2 Million	42,810 Added 6.37%	714,510 $29.3 Million
Q1 2021 May 07, 2021	BUY	$42.34 - $52.82 $10.3 Million - $12.8 Million	242,200 Added 56.39%	671,700 $29.3 Million
Q4 2020 Feb 05, 2021	BUY	$36.12 - $50.05 $15.5 Million - $21.5 Million	429,500 New	429,500 $21.5 Million

Others Institutions Holding RPRX

# of Institutions

410

Shares Held

284M

Call Options Held

499K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Royalty Pharma PLC Transaction History